Compare ABVX & VOYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | ABVX | VOYA |
|---|---|---|
| Founded | 2013 | 1975 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | | Life Insurance |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.7B | 8.6B |
| IPO Year | 2022 | 2012 |
| Metric | ABVX | VOYA |
|---|---|---|
| Price | $87.60 | $96.94 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 12 |
| Target Price | ★ $163.58 | $107.83 |
| AVG Volume (30 Days) | ★ 1.1M | 835.6K |
| Earning Date | 09-21-2026 | 11-02-2026 |
| Dividend Yield | N/A | ★ 1.95% |
| EPS Growth | N/A | ★ 1.94 |
| EPS | N/A | ★ 2.73 |
| Revenue | N/A | ★ $8,189,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1,695.54 | $4.42 |
| P/E Ratio | ★ N/A | $35.35 |
| Revenue Growth | N/A | ★ 1.73 |
| 52 Week Low | $69.81 | $64.50 |
| 52 Week High | $148.83 | $105.64 |
| Indicator | ABVX | VOYA |
|---|---|---|
| Relative Strength Index (RSI) | 41.52 | 51.20 |
| Support Level | $84.11 | $97.08 |
| Resistance Level | $99.59 | $99.53 |
| Average True Range (ATR) | 3.73 | 2.03 |
| MACD | 0.76 | 0.36 |
| Stochastic Oscillator | 33.71 | 74.05 |
Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. The company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD. The Group operates in a single operating segment: R&D of pharmaceutical products in order to market them in the future.
Voya Financial Inc is a financial services company, which, through its subsidiaries, provides various investment, insurance, and retirement solutions to individual and institutional clients in the United States. Its products and services include tax savings plans, individual retirement accounts, group life insurance plans, and employee benefits products, among others. The company tailors each of its products to the needs of its customer base. It operates its business through three principal lines: Retirement, Investment Management and Employee Benefits.The majority revenue is from Retirement segment.